Elisabeth Sandoval Little - 03 Jun 2022 Form 4 Insider Report for Satsuma Pharmaceuticals, Inc. (STSA)

Role
Director
Signature
/s/ Thomas P. O'Neil as Attorney in Fact for Elisabeth Sandoval
Issuer symbol
STSA
Transactions as of
03 Jun 2022
Net transactions value
$0
Form type
4
Filing time
07 Jun 2022, 17:37:31 UTC
Previous filing
16 May 2022
Next filing
09 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STSA Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 03 Jun 2022 Common Stock 30,000 $3.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shall vest in full and become exercisable on the day immediately preceding the 2023 Annual Meeting.